|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.82 NZD | +0.30% |
|
+1.09% | +7.48% |
| Jul. 02 | NZX Midday Sector Update: Retail Trade Soars, Health Technology Falls | MT |
| Jun. 02 | EBOS says AustralianSuper Becomes Substantial Holder | MT |
| Capitalization | 8.09B 4.85B 4.14B 3.86B 3.57B 6.64B 415B 7.42B 46.18B 17.57B 194B 18.18B 17.8B 710B | P/E ratio 2025 * |
27.7x | P/E ratio 2026 * | 23.1x |
|---|---|---|---|---|---|
| Enterprise value | 9.25B 5.54B 4.73B 4.41B 4.08B 7.59B 475B 8.49B 52.8B 20.09B 222B 20.79B 20.36B 812B | EV / Sales 2025 * |
0.7x | EV / Sales 2026 * | 0.66x |
| Free-Float |
80.47% | Yield 2025 * |
2.87% | Yield 2026 * | 3.19% |
More valuation ratios
* Estimated data
More news
Last Transcript: EBOS Group Limited
More recommendations
| EBOS : 2025 Half Year Results Investor Presentation | Feb. 18 | PU |
| EBOS : 2025 Interim Report | Feb. 18 | PU |
| Morgans rates EBO as Add | 24-08-22 | AQ |
| EBOS : 2024 Full Year Results Investor Presentation | 24-08-21 | PU |
| Ord Minnett rates EBO as Lighten | 24-02-21 | AQ |
More news
| 1 day | +0.30% | ||
| 1 week | +1.09% | ||
| Current month | +3.56% | ||
| 1 month | +5.51% | ||
| 3 months | +5.34% | ||
| 6 months | +7.48% | ||
| Current year | +7.48% |
| 1 week | 39.04 |  | 39.99 |
| 1 month | 36.02 | | 39.99 |
| Current year | 36.01 | | 42.55 |
| 1 year | 32.86 | | 42.55 |
| 3 years | 31.02 | | 46.75 |
| 5 years | 21.5 | | 46.75 |
| 10 years | 10 | | 46.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Luke Hall
CEO | Chief Executive Officer | 50 | 2025-06-30 |
Mithran Naiker
CTO | Chief Tech/Sci/R&D Officer | - | 2023-07-31 |
Andrew McLean
CTO | Chief Tech/Sci/R&D Officer | - | 2024-08-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Liz Coutts
CHM | Chairman | 65 | - |
| Director/Board Member | - | 2019-06-30 | |
Tracey Batten
BRD | Director/Board Member | 58 | 2021-06-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.30% | +1.09% | +20.92% | +2.58% | 4.85B | ||
| +0.43% | +3.09% | +23.93% | +119.57% | 90.98B | ||
| -0.12% | +1.41% | +71.09% | +210.39% | 39.21B | ||
| -1.38% | -5.00% | - | - | 21.78B | ||
| +0.99% | -1.25% | +47.80% | -13.33% | 9.65B | ||
| +0.06% | +1.07% | -6.10% | -1.10% | 8.38B | ||
| +1.52% | +0.75% | -4.30% | -5.08% | 7.32B | ||
| +0.45% | +0.40% | +17.89% | +15.43% | 5.54B | ||
| +1.41% | -1.83% | -15.10% | -6.72% | 5.14B | ||
| +0.19% | +2.73% | +10.74% | +19.85% | 3.65B | ||
| Average | +0.38% | -0.25% | +18.54% | +37.96% | 19.65B | |
| Weighted average by Cap. | +0.19% | -0.32% | +31.51% | +109.25% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 13.15B 7.88B 6.73B 6.27B 5.8B 10.79B 675B 12.07B 75.06B 28.56B 316B 29.55B 28.94B 1,154B | 14.07B 8.43B 7.2B 6.71B 6.2B 11.55B 722B 12.91B 80.3B 30.55B 338B 31.61B 30.96B 1,235B |
| Net income | 275M 165M 141M 131M 121M 226M 14.11B 252M 1.57B 597M 6.59B 617M 605M 24.12B | 334M 200M 171M 159M 147M 274M 17.13B 306M 1.9B 724M 8B 749M 734M 29.27B |
| Net Debt | 1.16B 696M 594M 554M 512M 953M 59.62B 1.07B 6.63B 2.52B 27.86B 2.61B 2.55B 102B | 1.13B 674M 576M 537M 497M 924M 57.82B 1.03B 6.43B 2.45B 27.01B 2.53B 2.48B 98.84B |
More financial data
* Estimated data
Employees
5,200
Sector
Pharmaceuticals
Calendar
Aug. 26
- Q4 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-09 | 39.82 $ | +0.30% | 162,306 |
| 25-07-08 | 39.70 $ | +0.63% | 339,256 |
| 25-07-07 | 39.45 $ | -0.13% | 102,766 |
| 25-07-04 | 39.50 $ | 0.00% | 74,877 |
| 25-07-03 | 39.50 $ | +0.28% | 126,806 |
End-of-day quote New Zealand S.E., July 08, 2025
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
39.82NZD
Average target price
39.95NZD
Spread / Average Target
+0.34%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EBO Stock
Select your edition
All financial news and data tailored to specific country editions
